Search
for
Sort by
Research 211–240 of 1000+
- Relapse of Alopecia Areata Responders After Tofacitinib Withdrawal: A Retrospective Study of 59 Patients
- FDA approval of Deuruxolitinib: A New Treatment Option for Severe Alopecia Areata
- The Importance of Readability: A Guide to Understanding Alopecia Areata through Multilingual Online Resources
- SDRIFE Induced by Tofacitinib
- Real-world experience quantifying access to JAK inhibitor care for alopecia areata patients: a patient-centered survey study
- Upadacitinib for management of recalcitrant alopecia areata: A retrospective case series
- Alopecias in humans: biology, pathomechanisms and emerging therapies
- LB785 Efficacy and safety of baricitinib in adults with Alopecia Areata: Phase 3 results from a randomized controlled trial (BRAVE-AA1)
- Recent Insight on the Management of Lupus Erythematosus Alopecia
- Improvement of Psoriasis, Psoriatic Arthritis, and Alopecia Universalis during Treatment with Tofacitinib: A Case Report
- 691 Topical curcumin promotes induction of the murine hair cycle
- Short-term malignancy risk of JAK inhibitors in severe alopecia areata: a multicenter cohort study
- Efficacy and safety of JAK inhibitors in treating lichen planopilaris or frontal fibrosing alopecia
- JAK-inhibitors in the therapy of comorbid diseases – atopic dermatitis and alopecia areata: literature review and experience of clinical practice
- Alopecia – New building blocks
- Hair regrowth in a patient with central centrifugal cicatricial alopecia after a 2-month trial of baricitinib
- Adverse events in patients treated with Jak‐inhibitors for alopecia areata: A systematic review
- Alopecia Areata Barbae in a Nutshell
- Real‐world experience and long‐term evaluation of tofacitinib in refractory alopecia areata: A prospective, open‐label, single‐center study in Asian Arab population
- Personalized Medicine in the Field of Inflammatory Skin Disorders
- Treatment of Crohn's Disease and Concomitant Alopecia Areata With Tofacitinib
- Response to “Reply to effectiveness of dutasteride in a large series of patients with FFA in real clinical practice”
- Topical tofacitinib in treatment of alopecia areata
- An urticarial drug eruption caused by tofacitinib for alopecia universalis
- Alopecia areata
- Hair Follicle Reconstruction and Stem Cells
- Two Birds that Exclude Each Other: The Renbök Phenomenon
- A pan-European register-based observational study of abrocitinib and conventional systemic therapies in moderate and severe atopic dermatitis: the DREAM TO TREAT AD study protocol
- Dermal T cell immunity and key regulatory signaling pathways: Implications in immune-mediated alopecia and hair regeneration
- Alopecia areata-like hair loss after a tick bite